Hepatitis B control in the World Health Organization's Western Pacific Region: Targets, strategies, status

Vaccine

Volumn 31, Issue S9, 2013, Pages

  Hennessey, Karen ^a   Mendoza Aldana, Jorge ^a   Bayutas, Benjamin ^a   Lorenzo Mariano, Kayla Mae ^a   Diorditsa, Sergey ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Hepatitis B control; Hepatitis B virus; Vaccination

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

AWARENESS; CAUSE OF DEATH; CHILD HEALTH CARE; DELIVERY; DRUG SAFETY; FINANCIAL MANAGEMENT; GOVERNMENT; GROUPS BY AGE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CENTER; HEPATITIS B; HEPATITIS B VIRUS; HOME DELIVERY; HUMAN; IMMUNIZATION; INFECTION CONTROL; INFECTION PREVENTION; MATERNAL CARE; MATERNAL MORTALITY; MONITORING; NEWBORN MORTALITY; PACIFIC ISLANDS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEROPREVALENCE; VACCINATION; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

HEPATITIS B CONTROL; HEPATITIS B VIRUS; VACCINATION;

CHINA; COMMUNICABLE DISEASE CONTROL; HEPATITIS B, CHRONIC; HUMANS; SURVIVAL ANALYSIS; WORLD HEALTH ORGANIZATION;

EID: 84892410738     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.10.082     Document Type: Review

References (49)

1. Rani M., Yang B., Nesbit R. Hepatitis B control by 2012 in the WHO Western Pacific Region: rationale and implications. Bull World Health Organ 2009, 87(September (9)):707-713.
2. Clements C.J., Baoping Y., Crouch A., Hipgrave D., Mansoor O., Nelson C.B., et al. Progress in the control of hepatitis B infection in the Western Pacific Region. Vaccine 2006, 24(March (12)):1975-1982.
3. Gust I.D. Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut 1996, 38(Suppl. 2):S18-S23.
4. Goldstein S.T., Zhou F., Hadler S.C., Bell B.P., Mast E.E., Margolis H.S. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005, 34(December (6)):1329-1339.
5. Hadziyannis S.J. Natural history of chronic hepatitis B in Euro-Mediterranean and African countries. J Hepatol 2011, 55(July (1)):183-191.
6. Iorio R., Giannattasio A., Cirillo F., DA L., Vegnente A. Long-term outcome in children with chronic hepatitis B: a 24-year observation period. Clin Infect Dis 2007, 45(October (8)):943-949.
7. Kramvis A., Kew M.C. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res 2007, 37(July (s1)):S9-S19.
8. Mast E.E., Margolis H.S., Fiore A.E., Brink E.W., Goldstein S.T., Wang S.A., et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 2005, 54(December (RR-16)):1-31.
9. Parkin D.M. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006, 118(June (12)):3030-3044.
10. Alcorn T. Mongolia's struggle with liver cancer. Lancet 2011, 377(April (9772)):1139-1140.
11. World Health Organization Progress towards meeting the 2012 hepatitis B control milestone: WHO Western Pacific Region, 2011. Wkly Epidemiol Rec 2011, 86(May (19)):180-188.
12. World Health Organization Regional Office for the Western Pacific. Guidelines for Certification of Achievement of Hepatitis B Control Goal in the Western Pacific Region. Manila, Philippines: WHO; 2007.
13. World Health Organization. WHO/UNICEF Joint Reporting Form on Immunization: WHO Vaccine Preventable Diseases Monitoring System; 2012 Available from: [cited 18.05.12]. http://apps.who.int/immunization_monitoring/en/globalsummary/countryprofileselect.cfm.
14. Burton A., Monasch R., Lautenbach B., Gacic-Dobo M., Neill M., Karimov R., et al. WHO and UNICEF estimates of national infant immunization coverage: methods and processes. Bull World Health Organ 2009, 87(July (7)):535-541.
15. World Health Organization. Documenting the Impact of Hepatitis B Immunization: best practices for conducting a serosurvey; 2011. Available from: [cited 02.07.12]. http://whqlibdoc.who.int/hq/2011/WHO_IVB_11.08_eng.pdf.
16. Liang X., Bi S., Yang W., Wang L., Cui G., Cui F., et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis 2009, 200(July (1)):39-47.
17. Danielsson N., Fakakovikaetau T., Szegedi E. Improved immunization practices reduce childhood hepatitis B infection in Tonga. Vaccine 2009, 27(July (33)):4462-4467.
18. Gidding H.F., Warlow M., MacIntyre C.R., Backhouse J., Gilbert G.L., Quinn H.E., et al. The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia. Vaccine 2007, 25(December (51)):8637-8641.
19. Weir R., Sheryl J.L., Brunton Y., Murdoch C.D. National serosurvey of vaccine preventable diseases 2009, Ministry of Health, Wellington, New Zealand.
20. Prevalence of hepatitis B markers in Singapore. Singapore; 2000.
21. Ng K.P., Saw T.L., Baki A., Rozainah K., Pang K.W., Ramanathan M. Impact of the Expanded Program of Immunization against hepatitis B infection in school children in Malaysia. Med Microbiol Immunol 2005, 194(May (3)):163-168.
22. Tanaka J., Kumagai J., Katayama K., Komiya Y., Mizui M., Yamanaka R., et al. Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000. Intervirology 2004, 47(1):32-40.
23. Cui F., Li L., Hadler S.C., Wang F., Zheng H., Chen Y., et al. Factors associated with effectiveness of the first dose of hepatitis B vaccine in China: 1992-2005. Vaccine 2010, 28(August (37)):5973-5978.
24. Cui F., Wang X.J., Cao L. Progress in hepatitis B prevention through universal infant immunization in China, 1997-2006. MMWR Morb Mortal Wkly Rep 2007, 56:441-445.
25. World Health Organization. Country Instructions for Verifying Achievement of Hepatitis B control Goals in the WHO Western Pacific Region 2011. Available from: [cited 24.07.12]. http://www.wpro.who.int/immunization/documents/HepBVerificationPackage_20110521v4.pdf.
26. World Health Organization. Western Pacific Regional Plan for Hepatitis B Control Through Immunization Manila: World Health Organization Regional Office for the Western Pacific; December 2007.
27. World Health Organization. Preventing mother-to-child transmission of hepatitis B: operational field guidelines for delivery of the birth dose of hepatitis B vaccine. Manila: World Health Organization Regional Office for the Western Pacific; 2006.
28. Wilson N., Ruff T.A., Rana B.J., Leydon J., Locarnini S. The effectiveness of the infant hepatitis B immunisation program in Fiji, Kiribati, Tonga and Vanuatu. Vaccine 2000, 18(July (26)):3059-3066.
29. Edstam J.S., Dulmaa N., Nymadawa P., Rinchin A., Khulan J., Kimball A.M. Comparison of hepatitis B vaccine coverage and effectiveness among urban and rural Mongolian 2-year-olds. Prev Med 2002, 34(February (2)):207-214.
30. Dumolard L., G-DM, Shapiro C.N., Wiersma S., Wang S.A. Implementation of newborn hepatitis B vaccination - worldwide, 2006. MMWR 2008, 57(46):1249-1252.
31. National Institute of Public Health, National Institute of Statistics [Cambodia], Macro O. Cambodia Demographic and Health Survey 2005. Phnom Penh, Cambodia and Calverton. MD, USA; 2006.
32. National Institute of Statistics, Directorate General for Health, ICF Macro. Cambodia Demographic and Health Survey. Phnom Penh, Cambodia and Calverton. MD, USA: National Institute of Statistics, Directorate General for Health, and ICF Macro; 2011.
33. Sobel H.L., Mantaring J.B., Cuevas F., Ducusin J.V., Thorley M., Hennessey K.A., et al. Implementing a national policy for hepatitis B birth dose vaccination in Philippines: lessons for improved delivery. Vaccine 2010, 29(January (5)):941-945.
34. Willis B.C., Wortley P., Wang S.A., Jacques-Carroll L., Zhang F. Gaps in hospital policies and practices to prevent perinatal transmission of hepatitis B virus. Pediatrics 2010, 125(April (4)):704-711.
35. Connors C.M., Miller N.C., Krause V.L. Universal hepatitis B vaccination: hospital factors influencing first-dose uptake for neonates in Darwin. Aust N Z J Public Health 1998, 22(February (1)):143-145.
36. Sobel H.L., Silvestre M.A., Mantaring J.B., Oliveros Y.E., Nyunt U.S. Immediate newborn care practices delay thermoregulation and breastfeeding initiation. Acta Paediatr 2011, 100(August (8)):1127-1133.
37. Chien Y.C., Jan C.F., Kuo H.S., Chen C.J. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. Epidemiol Rev 2006, 28:126-135.
38. Hipgrave D.B., Tran T.N., Huong V.M., Dat D.T., Nga N.T., Long H.T., et al. Immunogenicity of a locally produced hepatitis B vaccine with the birth dose stored outside the cold chain in rural Vietnam. Am J Trop Med Hyg 2006, 74(February (2)):255-260.
39. Wang L., Li J., Chen H., Li F., Armstrong G.L., Nelson C., et al. Hepatitis B vaccination of newborn infants in rural China: evaluation of a village-based, out-of-cold-chain delivery strategy. Bull World Health Organ 2007, 85(September (9)):688-694.
40. Sutanto A., Suarnawa I.M., Nelson C.M., Stewart T., Soewarso T.I. Home delivery of heat-stable vaccines in Indonesia: outreach immunization with a prefilled, single-use injection device. Bull World Health Organ 1999, 77(2):119-126.
41. Althabe F., Mazzoni A., Cafferata M.L., Gibbons L., Karolinski A., Armbruster D., et al. Using Uniject to increase the use of prophylactic oxytocin for management of the third stage of labor in Latin America. Int J Gynaecol Obstet 2011, 114(August (2)):184-189.
42. Coffey P.S., Sharma J., Gargi K.C., Neupane D., Dawson P., Pradhan Y.V. Feasibility and acceptability of gentamicin in the Uniject prefilled injection system for community-based treatment of possible neonatal sepsis: the experience of female community health volunteers in Nepal. J Perinatol 2012, March. [ePub ahead of print].
43. Quiroga R., Halkyer P., Gil F., Nelson C., Kristensen D. A prefilled injection device for outreach tetanus immunization by Bolivian traditional birth attendants. Rev Panam Salud Publica 1998, 4(July (1)):20-25.
44. Lee C., Gong Y., Brok J., Boxall E.H., Gluud C. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Database Syst Rev 2006, (2):CD004790.
45. World Health Organization Hepatitis B vaccines. Wkly Epidemiol Rec 2009, 84(October (40)):405-419.
46. World Health Organization. Western Pacific Country Health Information Profiles; 2011. Available from: [cited September 2012]. http://www.wpro.who.int/health_information_evidence/documents/CHIPS/en/index.html.
47. Lawn J.E., Cousens S., Zupan J. 4 million neonatal deaths: Whenα Whereα Whyα. Lancet 2005, 365(March (9462)):891-900.
48. World Health Organization. Vaccinating health-care workers against hepatitis B; 2012. Available from: [cited July 2012]. http://www.wpro.who.int/immunization/documents/docs/HepBVaccinatingHCW.pdf.
49. World Health Organization. Prevention and Control of Viral Hepatitis Infection: Framework for Global Action; 2012. Available from: [cited July 2012]. http://www.who.int/csr/disease/hepatitis/Framework/en/index.html.